Professional Documents
Culture Documents
Biosafety Guideline & Regulation (I) : Dr. Haryati Anuar Haryati@ucsiuniversity - Edu.my
Biosafety Guideline & Regulation (I) : Dr. Haryati Anuar Haryati@ucsiuniversity - Edu.my
REGULATION (I)
DR. HARYATI ANUAR
Haryati@ucsiuniversity.edu.my
Objectives
• The Biosafety Act 2007 describes the framework for the Malaysian
system of regulation for LMOs and product of such organisms and is
complemented by corresponding regulations and guidelines.
• The Act follows the normal structure of laws in Malaysia.
• The Act sets out the main features and delegates the way in which
the provisions are to be implemented to delegated legislation, in this
case, by regulations.
Activities involving LMOs
• There are five categories of activities involving LMOs that are
regulated by the Act.
• These are:
• i. Release;
• ii. Contained use;
• iii. Importation for release;
• iv. Importation for contained use; and
• v. Exportation.
Types of approvals involving LMOs
The Act prohibits the five activities earlier identified involving LMOs
unless these have been either:
• approved by the National Biosafety Board; or
• notified to the National Biosafety Board. Following is a brief summary
of these two types of “approvals” under the Act.
Pharmaceutical products of LMO
• There are 2 key elements to be fulfilled under this category for the
exemption to apply.
i. It must be a pharmaceutical product of LMOs; and
ii. It must be: a. addressed by relevant international treaties; or b.
addressed by relevant international organisations, or c. regulated under
any other written laws relating to pharmaceuticals.